BBC News Online: Health


Front Page | World | UK | UK Politics | Business | Sci/Tech | Health | Education | Sport | Entertainment | Talking Point | High Graphics | Feedback | Help | Noticias | Newyddion |
Wednesday, January 6, 1999 Published at 03:08 GMT

Scientists crack cancer secret


Scientists crack cancer secret
Scientists have found a way to make cancer cells commit suicide that could lead to the development of more effective drugs to combat breast cancer.

Normally, old or damaged cells are sent a chemical message to stop dividing and self-destruct to prevent any mutations being duplicated and growing into tumours.

Cancer cells usually ignore these messages and continue to multiply indefinitely and out of control.

An enzyme called telomerase is one of the factors responsible for protecting cancer cells from the natural ageing process.

Now a team funded by the Cancer Research Campaign has developed a way to "switch off" the enzyme.

Researcher Professor Robert Newbold, of Brunel University, West London, said: "We already know that telomerase is active in around 85% of cancers and is probably responsible for kick-starting the process that protects cancer cells from dying.

"However, our latest research has finally been able to pinpoint a new way to potentially de-activate this rogue enzyme."

In laboratory tests, groups of healthy genes carried on chromosomes were transferred into breast tumour tissue to ascertain which combination could potentially stop the gene that produces telomerase from working.

Professor Newbold said: "We have now identified chromosome 3 as the specific group of genes which has the ability to stop the further production of telomerase in breast tumours.

"By using advanced genetic techniques we have also been able to map the gene responsible to a small region of the chromosome."

The introduction of a normal copy of chromosome 3 into the breast cancer cells causes them to regain their normal ageing process and die.

Synthetic production


[ image: width=150]

Scientists will now be working on ways to mimic this group of genes.

It is hoped this will lead to the synthetic production of anti-cancer drugs to block telomerase and halt the growth of human tumours.

The CRC Director General, Professor Gordon McVie, said: "This research really is a major step forward in the hunt for new and improved treatments for breast cancer patients.

"It is also another example of how gene therapy is being developed to target tumours without causing damage to healthy cells as well."

Approximately 35,000 women a year are diagnosed with breast cancer in the UK. If caught early, there is an 80% chance of survival.


Health Contents

Background Briefings
Medical notes

Relevant Stories

Hopes for gentler cancer treatment (05 Jan 99 | Health)
Breast cancer gene breakthrough (03 Nov 98 | Health)
Breast cancer screening success (02 Nov 98 | Health)
Breast cancer death rates plummet (26 Oct 98 | Health)
Breast cancer vaccine on trial (01 Oct 98 | Health)
Breast cancer factfile (23 Sep 98 | Medical notes)
Jetlag explanation for breast cancer (20 Aug 98 | Health)
Better breast cancer screening 'could save lives' (06 Aug 98 | Health)

Internet Links

Cancer Research Campaign
Breast cancer links
Telomerase

The BBC is not responsible for the content of external internet sites.


Links to other Health stories


Front Page | World | UK | UK Politics | Business | Sci/Tech | Health | Education | Sport | Entertainment | Talking Point | High Graphics | Feedback | Help | Noticias | Newyddion |


Back to top | BBC News Home | BBC Homepage | ©